
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $40.4M | -- | -- | $0.07 | -- |
08/13/2025 | Q2 | $37.6M | -- | -- | $0.01 | -- |
05/13/2025 | Q1 | $32.8M | $36.8M | -$0.02 | -$0.04 | $0.02 |
03/05/2025 | Q4 | $31.9M | $33.6M | -$0.04 | -$0.07 | $0.03 |
11/13/2024 | Q3 | $36.7M | $35.5M | $0.00 | -$0.04 | $0.04 |
08/13/2024 | Q2 | $37.3M | $36.5M | $0.02 | $0.01 | $0.02 |
05/14/2024 | Q1 | $35.1M | $37.6M | $0.07 | -$0.07 | $0.14 |
03/05/2024 | Q4 | $49M | $46.6M | $0.05 | $0.01 | $0.04 |
11/13/2023 | Q3 | -- | -- | $0.20 | $0.09 | $0.12 |
08/14/2023 | Q2 | -- | -- | $0.07 | $0.01 | $0.06 |
05/11/2023 | Q1 | -- | -- | $0.04 | -$0.05 | $0.09 |
03/09/2023 | Q4 | -- | -- | -$0.14 | -$0.15 | $0.00 |
11/08/2022 | Q3 | -- | -- | -$0.09 | -$0.07 | -$0.03 |
08/09/2022 | Q2 | -- | -- | -$0.13 | -- | -- |
05/06/2022 | Q1 | -- | -- | -$0.12 | -- | -- |
03/02/2022 | Q4 | -- | -- | -$0.21 | -- | -- |
11/10/2021 | Q3 | -- | -- | -$0.11 | -- | -- |
08/06/2021 | Q2 | -- | -- | $0.53 | -- | -- |
05/07/2021 | Q1 | -- | -- | -$0.07 | -- | -- |
02/25/2021 | Q4 | -- | -- | -$0.12 | -- | -- |
11/04/2020 | Q3 | -- | -- | -$0.06 | -- | -- |
08/05/2020 | Q2 | -- | -- | $0.03 | -- | -- |
05/08/2020 | Q1 | -- | -- | $0.06 | -- | -- |
02/27/2020 | Q4 | -- | -- | -$0.09 | -- | -- |
10/29/2019 | Q3 | -- | -- | -$0.06 | -- | -- |
08/02/2019 | Q2 | -- | -- | -$0.06 | -- | -- |
04/26/2019 | Q1 | -- | -- | -$0.07 | -- | -- |
02/26/2019 | Q4 | -- | -- | -$0.79 | -- | -- |
10/30/2018 | Q3 | -- | -- | -$0.05 | -- | -- |
07/31/2018 | Q2 | -- | -- | -$0.40 | -- | -- |
05/04/2018 | Q1 | -- | -- | -$0.32 | -- | -- |
02/27/2018 | Q4 | -- | -- | -$0.46 | -- | -- |
10/31/2017 | Q3 | -- | -- | -$0.15 | -- | -- |
08/01/2017 | Q2 | -- | -- | -$0.05 | -- | -- |
05/02/2017 | Q1 | -- | -- | $0.42 | -- | -- |
02/23/2017 | Q4 | -- | -- | $0.02 | -- | -- |
10/28/2016 | Q3 | -- | -- | $0.06 | -- | -- |
07/28/2016 | Q2 | -- | -- | -$0.03 | -- | -- |
04/28/2016 | Q1 | -- | -- | -$0.03 | -- | -- |
02/26/2016 | Q4 | -- | -- | -$0.73 | -- | -- |
10/29/2015 | Q3 | -- | -- | -$0.52 | -- | -- |
Broadwind reported $36.8M worth of top line sales in its most recent quarter.
Broadwind announced earnings per share of -$0.02 which represents a beat of analyst forecast a -$0.04 per share.
Broadwind reported $4.3M that represents $0.19 per share over the last quarter.
Broadwind's earnings are forecast to grow from $0.05 per share to $0.02 per share next year representing an increase of 53.34%.
Broadwind's next earnings date is August 13, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.